Pharmacology, Toxicology and Pharmaceutical Science
Mouse
52%
Indoleamine 2,3 Dioxygenase
49%
Hepatitis B Virus
49%
Liver Injury
34%
Spermidine
32%
Toll Like Receptor Agonist
28%
Vaccination Policy
28%
Kynurenine
21%
Knockout Mouse
19%
SARS Coronavirus
18%
Receptor
18%
Cancer Model
18%
Combination Therapy
18%
Wild Type Mouse
18%
Galactosylceramide
17%
Immunoglobulin G Antibody
16%
Membrane Antigen
16%
Mouse Model
16%
Metastasis
16%
Mouth Cancer
16%
Lung Tumor
16%
Immunogenicity
16%
Hepatitis
16%
Wound Healing
16%
Inducible Nitric Oxide Synthase
16%
Toll Like Receptor 7
16%
Carbon Tetrachloride
16%
Neoplasm
16%
Cysteine Conjugate Beta Lyase
16%
Alpha Galactosylceramide
16%
Lyase Inhibitor
16%
Colon Tumor
16%
Tumor Microenvironment
16%
Cardiovascular Disease
16%
Vaccine
16%
Skin Injury
16%
Concanavalin A
16%
Carbon Tetrachloride-Induced Liver Fibrosis
16%
Adjuvant
16%
Androgen Receptor
16%
Messenger RNA
16%
Prostate Cancer
16%
Tryptophan
15%
Disease
13%
Coronavirinae
13%
Tumor Antigen
9%
Imiquimod
9%
Cytokine
9%
Lipopolysaccharide
9%
Interferon
9%
Immunology and Microbiology
Mouse
100%
Indoleamine 2,3-dioxygenase
81%
Liver Regeneration
49%
Hepatitis B Virus
49%
Knockout Mouse
36%
Vaccination Policy
32%
Vaccine Efficacy
32%
Wild Type Mouse
29%
Immune Response
22%
Interleukin-6
20%
Severe Acute Respiratory Syndrome Coronavirus 2
19%
Receptor Binding
19%
Regulatory T Cell
18%
Natural Killer T Cell
17%
COVID-19
17%
Immunoglobulin G Antibody
16%
Immunogenicity
16%
Viral Disease
16%
Antibody Response
16%
NALP3
16%
Colon
16%
Cytotoxic T Cell
16%
CD8
16%
Encephalomyocarditis Virus
16%
Dectin 1
16%
Adjuvant
16%
Cell Proliferation
12%
Body Weight
9%
Transgenics
9%
Survival Rate
8%
Macrophage
8%
Mononuclear Cell
8%
Imiquimod
8%
Proinflammatory Cytokine
8%
Humoral Immunity
7%
Titer
7%
Inflammatory Cytokine
7%
Inflammation Response
7%
Tumor Necrosis Factor
7%
Vaccine Adjuvant
6%
Wild Type
6%
HBsAg
5%
Hepatitis B Antigen
5%
Mortality Rate
5%
Activating Transcription Factor 4
5%
Hepatic Stellate Cell
5%
Immunoregulation
5%
Hepatitis B
5%
Keyphrases
Toll-like
21%
α-galactosylceramide (α-GalCer)
18%
Hepatitis B Surface Antigen (HBsAg)
16%
Encephalomyocarditis Virus
16%
Induced Nitric Oxide Synthase
16%
COVID-19 Vaccine
16%
Tumor Metastasis
16%
Regulating Function
16%
CD11b+
16%
Skin Wound Healing
16%
Invariant NKT Cells
16%
Mouse Model
16%
Suppression Effect
16%
Chromogenic in Situ Hybridization
16%
Cancer Model
16%
Anchorage-independent Aggregation
16%
NALP3
16%
SAS Cell
16%
Tumor Microenvironment
16%
Virus Infection
16%
Cysteine S-conjugate β-lyases
16%
Colon Tumor
16%
Indoleamine 2,3-dioxygenase 2
16%
Partial Hepatectomy
16%
Lethal Shock
16%
Combination Therapy
16%
CD8+ Tregs
16%
Liver Regeneration
16%
CD8+ Regulatory T Cells
16%
Lipopolysaccharide-induced
16%
Dectin-1
16%
CCl4-induced Liver Fibrosis
16%
Lung Tumor
16%
Murine Tumor Model
16%
Receptor Agonist
16%
Lipopolysaccharide
15%
Coronavirus Disease 2019 Vaccine
13%
Wild Mice
12%
KO Mice
10%
Invariant Natural Killer T Cells
9%
Imiquimod
9%
Hepatitis B Virus
8%
Mononuclear Cells
8%
Lung Neuroendocrine Neoplasms
7%
Inflammatory Cytokines
6%
HBV Transgenic Mice
6%
GalCer
6%
Liver
5%
NF-B
5%
